Understand the current and future treatment of metastatic breast cancer - Resources for individuals with MBC.
Three CDK inhibitor drugs Ibrance (palbociclib) Kisqali (ribociclib) Verzenio (abemaciclib) are now FDA approved.
Early phase clinical trial suggests Dostarlimab immunotherapy may advance treatment of endometrial cancer.
IMPower133 clinical trial leads to Tecentriq being first new approved initial treatment for SCLC in years.
Cancer Connect - Stages IIE - IV Aggressive Non Hodgkins Lymphoma
Personalized Medicine’s Quest to Utilize the Patient’s Own Immune System to Treat Their Cancer
Understand who is at risk for depression, how its detected and how best to manage depression with cancer.
Tagrissio, Tarceva and other TKI therapy for EGFR + NSCLC continue to evolve and improve survival.
What have you found that helps with neuropathy?
Chemotherapy damage to nerves can cause numbness, tingling, & a loss of sensation known as peripheral neuropathy.
Looking for women living with breast cancer for research study. The goal is to get your opinions about a new tool to…
First NET Center of Excellence Recognized:
Merkel Cell FDA Approves Keytruda
Update on polio virus clinical trial: UCSF;
Article sheds light on long term heart risks from chemotherapy:
John Hopkins Researchers develop new test to screen for esophageal cancer.
Curious if others have experience with Lartruvo working and are nervous about the new study results?
